The much-publicised increased resistance of pathogenic bacteria to conventional antibiotics has focused research effort on the characterization of new antimicrobial drugs. In this context, antimicrobial peptides (AMPs) extracted from animals are considered a promising alternative to conventional antibiotics. In recent years, freshwater crayfish species have emerged as an important source of bioactive compounds. In fact, these invertebrates rely on an innate immune system based on cellular responses and on the production of important effectors in the haemolymph, such as AMPs, which are produced and stored in granules in haemocytes and released after stimulation. These effectors are active against both Gram-positive and Gram-negative bacteria. In this review, we summarise the recent progress on AMPs isolated from the several species of freshwater crayfish and their prospects for future pharmaceutical applications to combat infectious agents.

Punginelli Diletta, S.D. (2022). The potential of antimicrobial peptides isolated from freshwater crayfish species in new drug development: A review. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 126, 1-10 [10.1016/j.dci.2021.104258].

The potential of antimicrobial peptides isolated from freshwater crayfish species in new drug development: A review

Punginelli Diletta;Schillaci Domenico;Mauro Manuela;Barone Giampaolo;Arizza Vincenzo;Mirella Vazzana
2022-01-01

Abstract

The much-publicised increased resistance of pathogenic bacteria to conventional antibiotics has focused research effort on the characterization of new antimicrobial drugs. In this context, antimicrobial peptides (AMPs) extracted from animals are considered a promising alternative to conventional antibiotics. In recent years, freshwater crayfish species have emerged as an important source of bioactive compounds. In fact, these invertebrates rely on an innate immune system based on cellular responses and on the production of important effectors in the haemolymph, such as AMPs, which are produced and stored in granules in haemocytes and released after stimulation. These effectors are active against both Gram-positive and Gram-negative bacteria. In this review, we summarise the recent progress on AMPs isolated from the several species of freshwater crayfish and their prospects for future pharmaceutical applications to combat infectious agents.
gen-2022
Punginelli Diletta, S.D. (2022). The potential of antimicrobial peptides isolated from freshwater crayfish species in new drug development: A review. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 126, 1-10 [10.1016/j.dci.2021.104258].
File in questo prodotto:
File Dimensione Formato  
Punginelli et al., 2022.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
paper.pdf

accesso aperto

Tipologia: Pre-print
Dimensione 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/522537
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 11
  • ???jsp.display-item.citation.isi??? ND
social impact